Health and population

A Comment on dementia and Alzheimer's disease costs, in the context of SDG 3, focusing specifically on the costs of care in Europe. Dementia is a syndrome characterized by progressive cognitive and functional impairment, most commonly caused by Alzheimer's disease and other neurodegenerative and cerebrovascular disorders. Costs of care increase dramatically with progressing disease severity, and increasing dementia prevalence due to ageing populations is raising concerns about the sustainability of future costs of dementia care. A new study shows that social welfare systems in Europe cover most of the direct costs of dementia, however they do not protect families and households against the burden of informal care. Meier and colleagues1 set out to calculate the economic costs of dementia in 11 European countries, by combining microdata from a population-based survey with estimates of dementia prevalence. Data for Austria, Belgium, Czechia, Denmark, Estonia, France, Germany, Italy, Slovenia, Spain, and Sweden was obtained from six waves of the Survey of Health, Ageing, and Retirement in Europe (SHARE). The survey captured out-of-pocket expenditures for health and social care as well as unpaid informal care. Costs attributable to dementia were estimated using linear regression, controlling for comorbidities and demographic factors. Finally, costs were combined with prevalence estimates to calculate the annual cost of dementia by country.
Elsevier, The Lancet Gastroenterology and Hepatology, Volume 7, July 2022

The Lancet Regional Health - Western Pacific, Volume 22, 2022, 100428

An Article on the burden of chronic hepatitis B and C infections in Japan, in the context of SDG 3, highlighting the need for improved screening strategies for hepatitis C virus and development of new therapies leading to a functional cure for hepatitis B virus.
A Review on the experiences of supporting individuals of young people who self-harm, in the context of SDG 3, calling for health-care services to address these individuals' needs and implement evidence-based interventions to offer a holistic approach to self-harm care.

Foundations of Art Therapy
Theory and Applications
2022, Pages 335-377

The chapter provides different ways art therapy supports mental health and mental health recovery and concludes with information about art therapy for specific disorders and in different settings.
This book chapter advances SDG #3 and #10 by focusing on polyphenols and flavonoids and their crucial role in decreasing AD symptoms. In addition, it highlights the neuroprotective role of various essential ingredients of plant extracts such as Icariside, Onjisaponin B, Asarones, Liquiritin, Tanshinone IIA (TIIA) and cryptotanshinone (CT), Ginsenoside Rg1, and n-Butylidenephthalide. The efficacy of green nanotechnology are also discussed.
A Series paper in the context of SDGs 11 and 12, analysing healthy city planning policy indicators for 25 cities across 19 countries, highlighting the need to strengthen policy frameworks for health-enhancing city planning, particularly in low-income and middle-income countries.

Nanotechnological Applications in Virology, Developments in Applied Microbiology and Biotechnology, 2022, Pages 195-218

This chapter aligns with the SDG goal 3 of good health and wellbeing by showing the role of nanotechnology in the diagnosis, treatment, and development of vaccines of these viral diseases. Nanotechnology could be a great ally for a new way to fight these viruses and treat these diseases.

International Review of Cell and Molecular Biology, Volume 368, 2022, Pages 143-212

This chapter aligns with the SDG goal 3 of good health and wellbeing by showing current approaches being used to modulate macrophage function in liver diseases and discuss the therapeutic potential of targeting macrophage subpopulations as a novel treatment strategy for patients with liver disorders.
This chapter takes research on loneliness in elderly and applies it to designing intervention programs to help prevent loneliness.